Healthcare Costs of Myocardial Infarction in Denmark: A Nationwide Registry-Based Cohort Study
Jensen, KJ; Morton, JI; Flege MM; Petersen, J; Ademi Z
Value in Health Regional Issues, Volume 48, July 2025

Reduced use of maintenance therapies among people with cystic fibrosis following initiation of elexacaftor/tezacaftor/ivacaftor in Australia
Råket HK, Milder T, Litchfield M, Jensen CB, Wang JN, Jimenez-Solem E, Petersen J et al.
Clinical Therapeutics, June 2025

Elexacaftor/tezacaftor/ivacaftor for cystic fibrosis: Impact on hospitalizations and health care resource utilization in a universal health care setting
Råket, HK; Ankarfeldt, MZ; Wang, JN; Pressler, T; Jensen-Fangel, S; Qvist, T; Faurholt-Jepsen, D; Jimenez-Solem, E; Petersen, J; Jensen, CB; TransformCF study group
Pulmonary Therapy, 11(2), 235-247, June 2025

Ten-year projection of adult epilepsy burden in Australia
Geethadevi, GM; Jensen, KJ; Kwan, P; Foster, E; Jackson, G; Chen, Z; Ademi, Z
Epilepsia, April 2025 

Sex disparities in advanced non-small cell lung cancer survival: A Danish nationwide study
Frost, MG; Jensen, KJ; Jimenez-Solem, E; Qvortrup, C; Andersen, JAL; Petersen, TS
Lung Cancer, 202, 108485, April 2025

Impact of elexacaftor/tezacaftor/ivacaftor on utilization of routine therapies in cystic fibrosis: Danish nationwide register study
Råket, HK; Jensen, CB; Wang, JN; Pressler, T; Olesen, HV; Skov, M; Jensen-Fangel, S; Petersen, J; Jimenez-Solem, E; TransformCF Study Group
Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society, 24(1), 105-111, January 2025​

​See all publications